Information:
Fel:
ID
29105
Beskrivning
Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study; ODM derived from: https://clinicaltrials.gov/show/NCT00566215
Länk
https://clinicaltrials.gov/show/NCT00566215
Nyckelord
Versioner (1)
- 2018-02-25 2018-02-25 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
25 februari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Type 2 NCT00566215
Eligibility Diabetes Mellitus, Type 2 NCT00566215
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00566215
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
age: 18 to 60 years.
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
bmi between 25 and 29,9 kg/m².
boolean
C1305855 (UMLS CUI [1])
Body Weight Variability Percent
Item
weight variance less than 5% in the last 3 months.
boolean
C0005910 (UMLS CUI [1,1])
C2827666 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C2827666 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
Diabetes Mellitus, Non-Insulin-Dependent
Item
previous diagnosis of diabetes type 2.
boolean
C0011860 (UMLS CUI [1])
Insulin Requirement | Insulin Associated with Pharmaceutical Preparations Oral
Item
insulin requirement, alone or along with oral agents
boolean
C0021641 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
C1514873 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
Comprehension Study Protocol
Item
capacity to understand the procedures of the study.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
Informed Consent
Item
to agree voluntarily to participate of the study, signing an informed consent.
boolean
C0021430 (UMLS CUI [1])
Anti-GAD antibody positive
Item
positive anti-gad antibodies
boolean
C1167896 (UMLS CUI [1])
Insulin Production Failure Probable | Insulin C-peptide measurement
Item
laboratorial signal of probable failure of insulin production, i. e., seric peptide c lesser than 1 ng/ml.
boolean
C0021641 (UMLS CUI [1,1])
C0033268 (UMLS CUI [1,2])
C0231174 (UMLS CUI [1,3])
C0033204 (UMLS CUI [1,4])
C0202100 (UMLS CUI [2])
C0033268 (UMLS CUI [1,2])
C0231174 (UMLS CUI [1,3])
C0033204 (UMLS CUI [1,4])
C0202100 (UMLS CUI [2])
Liver diseases | Liver Cirrhosis | Hepatitis, Chronic
Item
history of hepatic disease like cirrhosis or chronic active hepatitis.
boolean
C0023895 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0019189 (UMLS CUI [3])
C0023890 (UMLS CUI [2])
C0019189 (UMLS CUI [3])
Renal dysfunction | Creatinine measurement, serum | Gender
Item
kidney dysfunction (creatinine > 1,4 mg/dl in women and > 1,5 mg/dl in men).
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Liver Dysfunction | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
hepatic dysfunction: alt and/or ast 3x above upper normal limit.
boolean
C0086565 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
Neoplasms
Item
recent history of neoplasia (< 5 years).
boolean
C0027651 (UMLS CUI [1])
Adrenal Cortex Hormones Oral | Adrenal Cortex Hormones Injectable
Item
use of oral or injectable corticosteroids for more than consecutive 14 days in the last three months.
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C0086466 (UMLS CUI [2,2])
C1527415 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C0086466 (UMLS CUI [2,2])